Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Hair or fiber wrapped tightly around a toe can lead to serious injury if not treated quickly.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

Triphasic Progressive is more effective against hair loss.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Skin diseases are common and need more specialized care.

Stress likely causes hair loss in Formosan macaques.

Telogen Effluvium is a condition where more hair than usual falls out after stress or fever.

Postpartum hair loss usually stops within 4-6 months.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

Certain chemicals and drugs can cause hair loss.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

The study concluded that neonatal occipital alopecia is common, not caused by physical friction, and usually resolves on its own without treatment.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Some people with chronic hair loss may have thyroid autoimmunity.

Sandalore® improves hair growth and quality in people with hair loss.